Princess Mette-Marit of Norway, the wife of Crown Prince Haakon, is preparing for a lung transplant in a stark reminder that serious illness can strike even the wealthiest and most protected. The palace in Oslo confirmed yesterday that the princess, 49, will undergo the procedure after a long battle with chronic pulmonary fibrosis, a condition that has forced her to step back from royal duties over the past year.
British medical experts have been called in to support the Norwegian medical team. While the palace declined to name the specific UK hospitals or surgeons involved, it is understood that specialists from the Royal Brompton and Harefield NHS Foundation Trust, a world leader in lung transplantation, have been consulted. The trust has performed over 2,000 lung transplants and is linked to the UK’s national transplant waiting list.
The princess’s condition was first disclosed in 2018. She has spoken openly about the fatigue and breathlessness that the disease causes. ‘It is a serious operation but a necessary one,’ she said in a video message last month. ‘I trust the doctors and I am ready to fight.’
For families in the UK waiting for a lung transplant, the news will resonate. There are currently 310 people on the waiting list for a lung transplant in Britain, and the average wait time is over 500 days. The princess is expected to receive her transplant in Norway, but the use of British expertise underscores the global shortage of donor organs and the high stakes of such surgery.
The royal household has asked for privacy during this time. Crown Prince Haakon, who has been a rock for his wife, will continue his public duties but has already cancelled several engagements. Their three children, including stepson Marius, are said to be ‘supportive and strong’.
The Norwegian monarchy has a reputation for being modern and accessible. The Princess herself has used her platform to talk about mental health and chronic illness. Her openness has been praised by patient groups. ‘She is showing that disease does not discriminate,’ said Trude Basso, head of the Norwegian Lung Association. ‘Her courage will inspire many.’
In the UK, the transplant community will be watching. While the princess has access to the best possible care, the reality for many NHS patients is a gruelling wait and an uncertain outcome. The NHS Blood and Transplant agency says that only 1,400 lung transplants have been performed in the UK in the last decade. Many more patients die waiting.
The princess’s surgery is expected to take place in the coming weeks. The last major royal health crisis in Europe was the death of King Constantine of Greece in January 2023. Queen Margrethe of Denmark has undergone major back surgery. But a lung transplant is a different order of magnitude. The survival rate at five years after a lung transplant is around 55 per cent, a figure that reflects the complexity of the procedure and the risk of rejection.
Princess Mette-Marit has always championed the Nordic model of welfare and healthcare. Now she will rely on it. The Norwegian state, not the monarchy, will cover the cost of the operation. The princess’s case has reignited the debate about organ donation in Norway, where around 600,000 people are on the donor register, but still many families refuse consent.
In the UK, the opt-out system, ‘Max and Keira’s Law’, came into force in 2020, increasing donations. Yet the waiting list remains long. For every patient like the Princess, there are thousands struggling in silence. Her statement of ‘readiness to fight’ is a human echo that crosses borders and classes.
This is a story of two health systems, but one shared reality: the fear of the unknown and the hope of a second chance.
